HealthTop Stories

Doctors And Tech Merge To Identify Patients Who Don’t Take Their Medicines

Almost everybody skips a dose of a medicine sometime or the other. Such nonadherence can seem undamaging on a separate level, but costs billions of dollars every year to the U.S. health care system. Now, researchers at Johns Hopkins have demonstrated how to best verify nonadherent patients, merging tech with the perceptions from health care suppliers.

The research, posted online in Pediatric Nephrology, was carried out on a population of young teens with chronic kidney disorder, but probably holds lessons in how to trace nonadherence more normally.

“We wish to have better methods to understand who is nonadherent so we can concentrate our efforts better on those patients who might need more help or particular resources to enhance adherence,” claims Cozumel Pruette, lead author and assistant professor at Johns Hopkins Children’s Center for pediatrics.

“There are resources we can offer to drive adherence if we know who requires them.” Almost $68–150 Billion of avoidable health care prices in the U.S. have been credited to nonadherence.

On a related note, the venom of insects such as bees and wasps is full of elements that can slay bacteria. Regrettably, many of these elements are also harmful for mankind, making it unfeasible to employ them as antibiotic medicines.

After carrying out a systematic research of the antimicrobial characteristics of a toxin usually discovered in a wasp in South America, scientists at MIT have now made iterations of the peptide that are nontoxic to human cells but strong against bacteria.

In a mice study, the scientists discovered that their strongest peptide can completely remove Pseudomonas aeruginosa, a bacteria strain that causes infections and respiratory diseases and is defiant to most antibiotics.

“We have repurposed a poisonous molecule into one that is a feasible molecule to cure infections,” claims an MIT postdoc, Cesar de la Fuente-Nunez, to the media in an interview.

Show More

Ashley Johnson

Ashley Johnson has a Bachelor’s Degree in Medicines. With an experience of more than 4 years, she has a good reputation at ZMR Industry Journal and is known for her punctuality. With no doubt, Ashley is the perfect choice to spearhead the Health department. It is she who looks after each published article in this domain. Even the slightest change must be approved by her. In her free time, Ashley will be seen playing and cuddling with her dog, who she loves than anybody else.

Related Articles